We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The potential for selective pharmacological therapies through biased receptor signaling.
- Authors
Kenakin, Terry
- Abstract
The discovery that not all agonists uniformly activate cellular signaling pathways (biased signaling) has greatly changed the drug discovery process for agonists and the strategy for treatment of disease with agonists. Technological advances have enabled complex receptor behaviors to be viewed independently and through these assays, the bias for an agonist can be quantified. It is predicted that therapeutic phenotypes will be linked, through translational studies, to quantified scales of bias to guide medicinal chemists in the drug discovery process.
- Subjects
CELL communication; CELL receptors; DRUGS; EXPERIMENTAL pharmacology; TECHNOLOGICAL innovations; CHEMISTS
- Publication
BMC Pharmacology & Toxicology, 2012, Vol 13, p1
- ISSN
2050-6511
- Publication type
Article
- DOI
10.1186/2050-6511-13-3